Future Horizons in the European Coagulation Testing Market--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... business opportunities emerging in the coagulation market during the next five years. The report explores business and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides estimates of the test volume, as well as sales and market shares of leading competitors; ...
September 2012
500 pages
Future Horizons in the European Clinical Chemistry and Immunodiagnostics Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 100 Chemistry, TDM
US$ 14,800.00
... and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major ...
September 2012
900 pages
Future Horizons in the European Hematology and Flow Cytometry Markets--France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tests by Country
US$ 14,800.00
... hematology and flow cytometry markets during the next five years. The report explores future marketing and technological trends in five major European countries (France, Germany, Italy, Spain, UK); provides market share estimates, test volume forecasts, and instrument placements; compares features of leading ...
September 2012
450 pages
Akzo Nobel: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Akzo Nobel, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
45 pages
BASF: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market. Contains 57 pages and 10 tables
September 2012
57 pages
Bayer: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 66 pages and 17 tables
September 2012
66 pages
Dow: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 59 pages and 5 tables
September 2012
59 pages
DuPont: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 59 pages and 7 tables
September 2012
59 pages
Firmenich: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 47 pages and 5 tables
September 2012
47 pages
Givaudan: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 50 pages and 6 tables
September 2012
50 pages
IFF: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 65 pages and 8 tables
September 2012
65 pages
Kansai Paint: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Kansai Paint, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
31 pages
Makhteshim-Agan: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
A strategies assessment of Makhteshim-Agan, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
September 2012
24 pages
Mane: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 26 pages and 3 tables
September 2012
26 pages
Monsanto: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
A strategies assessment of Monsanto, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
September 2012
35 pages
Nippon Paint: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Nippon Paint, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
36 pages
Nufarm: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global agrochemical market. Contains 33 pages and 6 tables
September 2012
33 pages
PPG: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global paints and coatings market. Contains 54 pages and 7 tables
September 2012
54 pages
Robertet: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 21 pages and 3 tables
September 2012
21 pages
Sensient: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 45 pages and 8 tables
September 2012
45 pages
Sherwin-Williams: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
The strategic assessment of Sherwin-Williams, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the ...
September 2012
37 pages
Sumitomo: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
A strategies assessment of Sumitomo, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
September 2012
30 pages
Symrise: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 70 pages and 10 tables
September 2012
70 pages
Syngenta: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,480.00
A strategies assessment of Syngenta, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's ...
September 2012
25 pages
T. Hasegawa: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 33 pages and 4 tables
September 2012
33 pages
Takasago: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,600.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global flavor and fragrance market. Contains 46 pages and 4 tables
September 2012
46 pages
Valspar: Strategies, Financials, R&D, Marketing Tactics, Collaborations, Product Portfolio, M&A
US$ 1,560.00
... information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global paints and coatings market. Contains 30 pages and 5 tables
September 2012
30 pages
Future Horizons in the Global Sexually-Transmitted Disease Market
US$ 6,800.00
About this Report This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ...
August 2012
350 pages
Future Horizons in the Global Enteric Disease Market
US$ 7,840.00
About this Report This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, ...
August 2012
389 pages
Future Horizons in the Global Respiratory Disease Market
US$ 7,360.00
About this Report This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV ...
August 2012
366 pages
Future Horizons in the Global Adenovirus Diagnostic Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts ...
August 2012
205 pages
Future Horizons in the Global Campylobacter Diagnostic Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales ...
August 2012
230 pages
Future Horizons in the Global Chancroid Diagnostic Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by ...
August 2012
220 pages
Future Horizons in the Global Chlamydia Diagnostic Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,080.00
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by ...
August 2012
184 pages
Future Horizons in the Global CMV Diagnostic Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country
US$ 3,880.00
The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by ...
August 2012
231 pages
Future Horizons in the Global Coxsackievirus Diagnostic Market: US, Europe, JapanTest Volume and Sales Forecasts by Country
US$ 3,080.00
The report presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coxsackievirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales ...
August 2012
190 pages
Future Horizons in the Global Cryptosporidium Diagnostic Market: US, Europe, JapanTest Volume and Sales Forecasts by Country
US$ 3,080.00
The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales ...
August 2012
207 pages
